SCHEMBL7983632

SCHEMBL7983632

COc1cc2c(cc1OCCCN(C)C)nc(Nc1c(C)cccc1Cl)c1cncn12

nearest known ligand 0.79

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LCK P06239 20/20 0.79

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7980247 0.97 LCK (0.72) LCK
SCHEMBL7969967 0.96 LCK (0.80) LCK
SCHEMBL7980264 0.91 LCK (0.75) LCK
SCHEMBL7980248 0.90 LCK (0.84) LCK
SCHEMBL7970062 0.89 LCK (0.83) LCK
SCHEMBL7970084 0.89 LCK (1.00) LCK
SCHEMBL7982912 0.87 LCK (0.76) LCK
SCHEMBL7970060 0.85 LCK (0.76) LCK
SCHEMBL7969991 0.85 LCK (0.68) LCK
SCHEMBL7970742 0.84 LCK (0.93) LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US claimed
WO-1999009845-A1 IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-04 WO claimed
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US disclosed